Amid the hand-wringing and back-pedaling surrounding renal denervation, some physicians are still looking for ways to use the technology to treat patients with hypertension.
Attendees at this year’s EuroPCR conference in Paris cast a wary eye on medical device makers’ efforts to promote renal denervation in treatment of hypertension, taking to Twitter to note and sometimes chide companies for putting "marketing before science."
A string of presentations and poster sessions during this week’s Heart Rhythm conference pitted device makers against each other in the battle for battery superiority.
Social media and healthcare are permanently intertwined, according to 3 of cardiology’s most prominent online voices. Drs. Kevin Campbell, Westby Fisher and Dave Albert spoke today about the benefits of having an active online presence to complement interaction in the field.
It’ll take a village to ensure that medical devices are ready to face the increasingly threat-laden wireless world, speakers told a group of clinicians this week during Heart Rhythm 2014, the Heart Rhythm Society’s 35th Annual Scientific Sessions.
There’s a tsunami of consumer-generated health data on the horizon and care providers would do well to get on board, AliveCor founder and chief medical officer Dr. Dave Albert told an audience today at Heart Rhythm 2014, the Heart Rhythm Society’s 35th Annual Scientific Sessions.
Remotely monitored pacemaker patients devices may get a major leg up over patients without the extra surveillance, researchers reported today during Heart Rhythm 2014, the Heart Rhythm Society’s 35th Annual Scientific Sessions in San Francisco.